These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 23748197)

  • 1. Subthalamic nucleus modulates social and anxogenic-like behaviors.
    Reymann JM; Naudet F; Pihan M; Saïkali S; Laviolle B; Bentué-Ferrer D
    Behav Brain Res; 2013 Sep; 252():356-62. PubMed ID: 23748197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep brain stimulation of the subthalamic nucleus in the 6-hydroxydopamine rat model of Parkinson's disease: effects on sensorimotor gating.
    Lindemann C; Krauss JK; Schwabe K
    Behav Brain Res; 2012 Apr; 230(1):243-50. PubMed ID: 22330948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal ganglia neural responses during behaviorally effective deep brain stimulation of the subthalamic nucleus in rats performing a treadmill locomotion test.
    Shi LH; Luo F; Woodward DJ; Chang JY
    Synapse; 2006 Jun; 59(7):445-57. PubMed ID: 16521122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subthalamic nucleus stimulation and lesioning have distinct state-dependent effects upon striatal dopamine metabolism.
    Walker RH; Koch RJ; Moore C; Meshul CK
    Synapse; 2009 Feb; 63(2):136-46. PubMed ID: 19021215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral subthalamic nucleus lesion reverses L-dopa-induced motor fluctuations and facilitates dyskinetic movements in hemiparkinsonian rats.
    Marin C; Jiménez A; Tolosa E; Bonastre M; Bové J
    Synapse; 2004 Feb; 51(2):140-50. PubMed ID: 14618681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep brain stimulation of the pedunculopontine tegmental nucleus modulates neuronal hyperactivity and enhanced beta oscillatory activity of the subthalamic nucleus in the rat 6-hydroxydopamine model.
    Alam M; Heissler HE; Schwabe K; Krauss JK
    Exp Neurol; 2012 Jan; 233(1):233-42. PubMed ID: 22036687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subthalamic discharges as a causal determinant of parkinsonian motor deficits.
    Tai CH; Pan MK; Lin JJ; Huang CS; Yang YC; Kuo CC
    Ann Neurol; 2012 Sep; 72(3):464-76. PubMed ID: 23034918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
    Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
    J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premature responding following bilateral stimulation of the rat subthalamic nucleus is amplitude and frequency dependent.
    Desbonnet L; Temel Y; Visser-Vandewalle V; Blokland A; Hornikx V; Steinbusch HW
    Brain Res; 2004 May; 1008(2):198-204. PubMed ID: 15145757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABAA-receptor activation in the subthalamic nucleus compensates behavioral asymmetries in the hemiparkinsonian rat.
    Petri D; Pum M; Vesper J; Huston JP; Schnitzler A
    Behav Brain Res; 2013 Sep; 252():58-67. PubMed ID: 23727148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequency stimulation and temporary inactivation of the subthalamic nucleus reduce quinpirole-induced compulsive checking behavior in rats.
    Winter C; Mundt A; Jalali R; Joel D; Harnack D; Morgenstern R; Juckel G; Kupsch A
    Exp Neurol; 2008 Mar; 210(1):217-28. PubMed ID: 18076877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with neuropsychiatric side effects after STN-DBS in Parkinson's disease.
    Witt K; Daniels C; Volkmann J
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S168-70. PubMed ID: 22166423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anterior olfactory organ removal produces anxiety-like behavior and increases spontaneous neuronal firing rate in basal amygdala.
    Contreras CM; Gutiérrez-García AG; Molina-Jiménez T
    Behav Brain Res; 2013 Sep; 252():101-9. PubMed ID: 23721965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep brain stimulation of the subthalamic nucleus increases premature responding in a rat gambling task.
    Aleksandrova LR; Creed MC; Fletcher PJ; Lobo DS; Hamani C; Nobrega JN
    Behav Brain Res; 2013 May; 245():76-82. PubMed ID: 23434606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subthalamic responses to amphetamine and apomorphine in the behaving rat with a unilateral 6-OHDA lesion in the substantia nigra.
    Olds ME; Jacques DB; Kopyov O
    Synapse; 1999 Dec; 34(3):228-40. PubMed ID: 10523760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subthalamic nucleus lesions alter basal and dopamine agonist stimulated electrophysiological output from the rat basal ganglia.
    Zahr NM; Martin LP; Waszczak BL
    Synapse; 2004 Nov; 54(2):119-28. PubMed ID: 15352137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo-controlled chronic high-frequency stimulation of the subthalamic nucleus preserves dopaminergic nigral neurons in a rat model of progressive Parkinsonism.
    Harnack D; Meissner W; Jira JA; Winter C; Morgenstern R; Kupsch A
    Exp Neurol; 2008 Mar; 210(1):257-60. PubMed ID: 18036524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
    Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
    Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing extracellular potassium results in subthalamic neuron activity resembling that seen in a 6-hydroxydopamine lesion.
    Strauss U; Zhou FW; Henning J; Battefeld A; Wree A; Köhling R; Haas SJ; Benecke R; Rolfs A; Gimsa U
    J Neurophysiol; 2008 Jun; 99(6):2902-15. PubMed ID: 18385482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.